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Available online 28 August 2016Hypericum androsaemum L. ethanol:water extract acted as a lipid peroxidation inhibitor and free radical scaven-
ger. Amarked inhibition of the growth of breast, lung, cervical and hepatocellular human carcinoma cell lineswas
also observed, whereas no toxicity was shown against non-tumor porcine liver cells (N400 μg/mL). The extract
was also effective in inhibiting nitric oxide production, as an indicator of the anti-inﬂammatory potential. The
anti-Candida effects varied among different strains of the same species, C. glabrata and C. tropicalis being the
most sensible species with an effect directly related with the extract concentrations tested. A signiﬁcant anti-
bioﬁlm formation potential was also observed, namely for C. glabrata and C. tropicalis (bioﬁlm reduction
N90%). 5-O-Caffeoylquinic and 3-O-caffeoylquinic acids were themost abundant phenolic compounds identiﬁed
in the extract, and might be related with the observed bioactive effects. Nevertheless, future studies should be
carried out to obtain dose-response curves of the isolated active compounds, in order to perform further pre-
clinically testing to quantify the presence of the most active compounds in the extract.
© 2016 Elsevier Ltd. All rights reserved.Keywords:
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Medicinal plants have been used over years for multiple purposes,
and have increasingly attracted the interest of researchers in order to
evaluate their contributes to health maintenance and disease's preven-
tion (Murray and Gramercy Books, 2004). Several studies have been
carried out, but numerous active principles directly responsible for the
observed bioactive properties remain unknown, while in other cases
the mechanism of action is not fully understood.
Hypericum species (Hypericaceae family; nearly about 450 species)
are examples of these plants, being Hypericum perforatum L. the most
widely known and with attributed anti-depressive, anti-inﬂammatory,
antitumor, antimicrobial, antioxidant and antiviral beneﬁts (Nogueira
et al., 2013; Rainha, Lima, & Baptista, 2011; Ramalhete et al., 2016).
However, based on recent ﬁndings, other Hypericum species have, iferreira@ipb.ptalso revealed very interesting functional properties. Hypericum
androsaemum L., commonly known as sweet-amber, has a popular
use as cholagogue, hepatoprotector, nephroprotective and diuretic
(Guedes, Amorim, Vicente, Ramos, & Fernandes-Ferreira, 2003). In
fact, Hypericum species are also used for culinary and cosmetic pur-
poses and, in particular, the use of H. androsaemum as a spice, herbal
tea and even its external application in wounds and burns (due to its
healing potential) is also highly recommended (Mazandarani, Yassaghi,
Rezaei, Mansourian, & Ghaemi, 2007).
The antioxidant potential of a H. androsaemum aqueous extract pre-
pared from the whole plant (Hernandez, Falé, Araújo, & Serralheiro,
2010; Ramos, Marques, Fernandes-Ferreira, & Pereira-Wilson, 2013),
aerial parts (Rainha et al., 2011) and leaves (Valentão et al., 2002) has
been described. In addition, the hepatoprotective effects of aqueous ob-
tained from leaves have been reported, and directly correlated with
their antioxidant capacity (Valentão et al., 2004). The antitumor poten-
tial of H. androsaemum aqueous extracts was also studied (Xavier, Lima,
Fernandes-Ferreira, & Pereira-Wilson, 2012), through the evaluation of
their anti-proliferative and pro-apoptotic effects in human colorectal
cancer cells. It is important to highlight that no reports have been
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portance once inﬂammation is not only a consequence of the free radi-
cals overproduction, but also a cause of numerous disorders, such as
neurodegenerative and cardiovascular diseases, and even cancer
(Valko et al., 2007). Regarding antimicrobial effects, thosewere only de-
scribed for ethanol extracts obtained from the aerial parts (Nogueira
et al., 2013). In fact, opportunistic fungal infections constitute a serious
threat to human health and wellbeing (Lott, Fundyga, Kuykendall, &
Arnold, 2005), and for many years, Candida albicans has been designat-
ed as the most widespread involved opportunistic pathogenic yeast
(Guinea, 2014). However, other non-C. albicans Candida (NCAC) species,
such as C. glabrata, C. tropicalis and C. parapsilosis, have been already and
increasingly isolated mainly due to the indiscriminate prescription of
antifungal agents (Estivill, Arias, Torres-Lana, Carrillo-Munoz, &Arevalo,
2011; Gacser, Schafer, Nosanchuk, Salomon, & Nosanchuk, 2007; Kuhn,
Chandra,Mukherjee, & Ghannoum, 2002). More interestingly is that the
pathogenesis of candidiasis is common to all Candida species and facili-
tated by several virulent factors (Silva et al., 2012). Themajor virulence
factor of Candida species is its ability to adapt to a variety of different
habitats, with the consequent formation of surface-attached microbial
communities known as bioﬁlms (Chandra et al., 2001; Douglas, 2003;
Ganguly & Mitchell, 2011). Therefore, the presence of persists in
the Candida bioﬁlm greatly tolerates high dose of fungicidal (Lewis,
2007), which complicates the clinical therapy for the nosocomial
infections (Moran, Grussemeyer, Spalding, Benjamin, & Reed, 2010).
Thus, the assessment of the bioﬁlm formation inhibitory potential of
H. androsaemummay be conceived as a promissory antifungal therapy.
The composition of H. androsaemum in terms of phenolic com-
pounds has been analyzed by some authors, namely in aqueous
(Valentão et al., 2002; Valentão et al., 2004) and methanol (Porzel,
Farag, Mülbradt, & Wessjohann, 2014; Valentão et al., 2003) extracts
from leaves and aerial parts (Rainha et al., 2011; Ramalhete et al.,
2016). Nevertheless, there are no studies reporting different bioactive
properties (antioxidant, cytotoxic, anti-inﬂammatory and anti-Candida
properties) in a speciﬁc extract of H. androsaemum (ethanol: water,
80:20, v/v), and relating them with its phenolic composition, which
was carried out in the present work. The biological effects to be tested
were selected based on the fact that high levels of oxidative stress pro-
motes inﬂammation, as also immune system weakening, cell damages,
and consequently enhances the growth of cancerous cells. Otherwise,
inﬂammatory, infectious and also carcinogenic processes involve free
radicals overproduction, which needs to be controlled. Furthermore,
numerous bioactive ingredients derived from plants and other natural
matrices have been increasingly applied as food ingredients, not only
for organoleptic purposes but also for nutritional and even health-
enhancing purposes. Therefore, the study of upcoming natural matrices
may be also conceived not only as a source of effective and upcoming
therapies, but also a way to discover promissory bioactive molecules
for food industry and even pharmaceutical purposes.
2. Material and methods
2.1. Plant material and preparation of the ethanol:water extract
Aerial parts of Hypericum androsaemum L., namely leaves, ﬂowers
and inﬂorescences were provided by “Cantinho das Aromáticas”, an or-
ganic and certiﬁed farm fromVila Nova de Gaia, Portugal and the botan-
ical identiﬁcation was conﬁrmed by the botanist, Dr. Carlos Aguiar from
School of Agriculture at the Polytechnic Institute of Bragança, Portugal.
The dried sampleswere reduced to powder and submitted to the fol-
lowing extraction procedure, at room temperature (~25 °C), in three in-
dependent experiments: 4 g were stirred with 30 mL of ethanol: water
(80:20, v/v) for 1 h, ﬁltered and re-extracted twice in the same condi-
tions. Ethanol was removed in a rotary evaporator (Büchi R-210, Flawil,
Switzerland), while water was removed by lyophilisation (−48 °C and
0.100 mbar, during 2–3 days, FreeZone 4.5, Labconco, Kansas City, MO,USA). Stock solutions of the extract were prepared with water:
5 mg/mL (for antioxidant activity assays), 8 mg/mL (for antitumor and
anti-inﬂammatory activity assays) and 50 mg/mL (for anti-Candida ac-
tivity assays), from which several dilutions were performed. Different
concentrations were used for each in vitro assay due to the different pa-
rameters of sensitivity, speciﬁcity and reliability of the techniques. For
phenolic compounds analysis the extract (2.5 mg/mL) was ﬁltered
through a 0.45 μm Whatman syringe ﬁlter and transferred to an
amber HPLC vial for chromatographic injection.
2.2. Standards and reagents
HPLC grade acetonitrile 99.9% and analytical grade purity ethanol
were from Fisher Scientiﬁc (Lisbon, Portugal). 2,2-Diphenyl-1-
picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA,
USA). Formic and acetic acidswere purchased fromProlabo (VWR Inter-
national, France). Trolox (6-hydroxy-2,5,7, 8-tetramethylchroman-2-
carboxylic acid), sulforhodamine B, trypan blue, trichloroacetic acid
(TCA), Tris, 3-(N-Morpholino)propanesulfonic acid (MOPS) and RPMI
1640 medium were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). Sabouraud Dextrose Broth (SDB) and Sabouraud Dextrose
Agar (SDA) were fromMerck (Darmstadt, Germany). Dulbecco's modi-
ﬁed Eagle's medium, Hank's balanced salt solution (HBSS), fetal bovine
serum (FBS), L-glutamine, trypsin-EDTA, penicillin/streptomycin solu-
tion (100 U/mL and 100 mg/mL, respectively), were purchased from
Gibco Invitrogen Life Technologies (California, USA). RAW264.7 cells
were purchased from ECACC (“European Collection of Animal Cell Cul-
ture”) (Salisburg, UK), lipopolysaccharide (LPS) from Sigma and
DMEMmedium from HyClone. The Griess Reagent System Kit was pur-
chased from Promega, and dexamethasone from Sigma. Water was
treated in a Milli-Q water puriﬁcation system (TGI PureWater Systems,
Greenville, SC, USA).
2.3. Evaluation of the antioxidant activity
Scavenging effects on DPPH (2,2-diphenyl-1-picrylhydrazyl) radi-
cals (RSA): an ELX800 microplate Reader (Bio-Tek Instruments,
Inc.; Winooski, VT, USA) was used to evaluate and to calculate the
percentage of DPPH discolouration through the formula:
[(ADPPH− AS) / ADPPH] 100, where AS is the absorbance of the solu-
tion containing the extract solution at 515 nm, and ADPPH is the ab-
sorbance of the DPPH solution (Martins, Barros, Dueñas, Santos-
Buelga, & Ferreira, 2015).
Reducing power (measured by ferricyanide Prussian blue assay)
(RP): through this assay the capacity to convert Fe3+ into Fe2+
was assessed,measuring the absorbance at 690 nm in themicroplate
Reader above mentioned (Martins et al., 2015).
β-carotene bleaching inhibition (CBI): was determined by the β-
carotene/linoleate assay. The absorbance at zero time and after 2 h
was measured at 470 nm in a spectrophotometer (AnalytikJena,
Jena, Germany). The neutralization of linoleate free radicals avoids
β-carotene bleaching, which was calculated by the formula: β-
carotene absorbance after 2 h of assay / initial absorbance) × 100
(Martins et al., 2015).
Lipid peroxidation inhibition (LPI): this assay was based on the abil-
ity to decrease thiobarbituric acid reactive substances (TBARS) gen-
eration in porcine brain cell homogenates, which was used as a
direct indicator of the antioxidant potential of extract. The color in-
tensity of the malondialdehyde-thiobarbituric acid (MDA-TBA) ad-
duct was measured by its absorbance at 532 nm and the inhibition
ratio (%) was calculated using the following formula: [(A − B) /
A] × 100%, where A and B were the absorbance of the control and
the extract solution, respectively (Martins et al., 2015).
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ried out and the results were expressed as EC50 values, which corre-
spond to the extract concentration providing 50% of antioxidant
activity or 0.5 of absorbance in the reducing power assay. Trolox was
used as positive control.
2.4. Evaluation of the cytotoxic activity
2.4.1. In human tumor cell lines
In order to perform a complete in vitro cytotoxicity screening, four
human tumor cell lines were selected: HeLa (cervical carcinoma),
HepG2 (hepatocellular carcinoma), MCF-7 (breast adenocarcinoma)
andNCI-H460 (non-small cell lung cancer), being among themost repre-
sentative carcinoma cell lines. In all cases the cell lines were plated in 96-
well plates, with a ﬁnal density of 1.0 × 104 cells/well, and were allowed
to attach for 24 h. Then, various extract concentrationswere added to the
cells and incubatedduring 48 h. Afterwards, cold trichloroacetic acid (TCA
10%, 100 μL) was used in order to bind the adherent cells and further in-
cubated for 60 min at 4 °C. After the incubation period, the plates were
washed with deionised water and dried, and sulforhodamine B solution
(SRB 0.1% in 1% acetic acid, 100 μL) was added to each plate well and in-
cubated for 30 min at room temperature. Then, the plates were washed
with acetic acid (1%) in order to remove the unbound SRB and air dried,
the bounded SRB was solubilised with Tris (10 mM, 200 μL) and the
absorbance was measured at 540 nm using an ELX800microplate reader
(Bio-Tek Instruments, Inc.; Winooski, VT, USA) (Abreu et al., 2011).
2.4.2. In non-tumor porcine liver cells (PLP2)
Liver tissues were rinsed in Hank's balanced salt solution containing
100 U/mL of penicillin and 100 μg/mL of streptomycin, and then divided
into 1 × 1mm3 explants. Some of these explants were placed in 25 cm3
tissue ﬂasks, containing DMEM and supplemented with 10% fetal bo-
vine serum, 2 mM of non-essential amino acids, 100 U/mL of penicillin
and 100mg/mL of streptomycin, and then incubated at 37 °Cwith a hu-
midiﬁed atmosphere containing 5% CO2. This medium was changed
every 2 days, and the cells cultivation continued under direct monitor-
ing every 2–3 days using a phase contrast microscope. Prior to conﬂu-
ence, cells were sub-cultured and plated in 96-well plates, with a ﬁnal
density of 1.0 × 104 cells/well and cultivated in DMEM medium, con-
taining 10% FBS, 100 U/mL of penicillin and 100 μg/mL of streptomycin
(Abreu et al., 2011). Then, cells were treated for 48 h with the different
diluted sample solutions. Three independent experiments were carried
out and the resultswere expressed inGI50 values, i.e. the extract concen-
tration that inhibited 50% of the net cell growth. Ellipticine was used as
positive control.
2.5. Evaluation of the anti-inﬂammatory activity
The mouse macrophage-like cell line RAW264.7 was cultured in
DMEM medium, supplemented with 10% heat-inactivated fetal bovine
serum and L-glutamine, at 37 °C under 5% CO2, in humidiﬁed air. Cells
were detached with a cell scraper, the experimental cell density
established in 5 × 105 cells/mL and the proportion of cell dead lesser
than 1%, according to Trypan blue dye exclusion tests. Then, cells were
seeded in 96-well plates at 150.000 cells/well and their attachment to
the plate allowed overnight. Afterwards, cells were treated with differ-
ent concentrations of the extract for 1 h. The next step consisted in the
stimulation with LPS (1 μg/mL) for 18 h, and the effect of the tested ex-
tracts in the absence of LPS was also assessed. To the negative controls
no LPS was added. Through this procedure it was possible to observe
the occurrence of induced changes inNObasal levels. For that, the tested
sample and LPS were dissolved in supplemented DMEM, and nitric
oxide content was determined using a Griess Reagent System kit
(Promega) containing sulfanilamide, NED and nitrite solutions. One
hundred microliters of the cell culture supernatant were transferred to
the plate and mixed with sulfanilamide and NED solutions, for 5–10 min, at room temperature. Nitrite level produced was determined
by measuring optical density at 515 nm, in a microplate reader, and
then compared with the standard calibration curve. Dexamethasone
(50 μM) was used as positive control. Three independent experiments
were carried out and the results were expressed in EC50 values, i.e. the
extract concentration that inhibited 50% of the NO production.
2.6. Evaluation of the anti-Candida activity
2.6.1. Yeast strains
Eight Candida strains belonging to the species C. albicans, C. glabrata,
C. parapsilosis and C. tropicalis were used in this study. Four of them
were from the American Type Culture Collection (ATCC), namely
C. albicans ATCC 90028, C. glabrata ATCC 2001, C. parapsilosis ATCC
22019 and C. tropicalis ATCC 750, while the other four were clinical iso-
lates from the archive collection of the Laboratory of Medical Mycology,
Universidade Estadual de Maringá, Brazil. In each experiment, Candida
strains were sub-cultured overnight in SDA or SDB, at 37 °C, and then
cellular density adjusted using a Neubauer chamber.
2.6.2. Effect on Candida planktonic cells
A) Minimal inhibitory concentration (MIC)
The antifungal activity of the H. androsaemum ethanol:water extract
was determined by the broth microdilution method according to CLSI
standard M27-A3 (Clinical and Laboratory Standards Institute, 2008),
with some modiﬁcations as described for natural products (Dalben-
Dota et al., 2010). For this, serial dilutions were performed at a ratio of
2, from 1:2 to 1:1024. In this way, the concentrations tested of the ex-
tract ranged from 0.02 to 12.5 mg/mL. The test was carried out in
RPMI 1640 with L-glutamine (with sodium bicarbonate) and 0.165 M
3-(N-morpholino)-propanesulfonic acid (pH 7.2) as buffer, supple-
mented with 2% glucose, in 96-well ﬂat-bottomed microtiter plates
(Orange Scientiﬁc, Braine-l′ Alleud, Belgium). After incubation at 37 °C
for 24 h,MICwere determined by direct observation. After visualization
of the resultant plate, theMIC values were determined as the antifungal
concentration where there was no growth or even fungistatic effect, by
comparison with the control (cells grown without extract). Then, the
number of cultivable cells was assessed by the determination of number
of colony forming units (CFUs), through several dilutions. After 24 h of
incubation at 37 °C, the number of colonies formed was counted. The
results were presented as total CFUs (log CFUs) and the experiments
repeated in triplicate on three different occasions.
B) Time-kill curve determination
Time kill curves were performed for the four Candida reference
strains, C. albicans ATCC 90028, C. glabrata ATCC 2001, C. parapsilosis
ATCC 22019 and C. tropicalis ATCC 750 with slight modiﬁcations to that
previously described (Klepser, Wolfe, Jones, & Nightingale, 1997). Prior
to testing, fungi were subcultured on SDA and the inoculum adjusted to
1–5 × 105 yeasts/mL, in RPMI 1640 medium, using a Neubauer chamber.
Then, each Candida strain suspension was grown in the presence of the
H. androsaemum ethanol:water extract at a concentration of 25 mg/mL.
The RPMI 1640mediumwithout plant extractwas used as a positive con-
trol. Test suspensions were placed on a shaker and incubated at 37 °C. At
predetermined time points (0, 1, 2, 4, 6, 8, 12, and 24 h), serial dilutions
were performed on SDA for colony-forming units (CFU) determination.
Following incubation at 37 °C for 24 h, the number of CFU was
determined.
C) Cell membrane lesion determination
Flow cytometry analyses using propidium iodide (PI; Sigma) were
performed to determine the effect of theH. androsaemum ethanol:water
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cells (106 cells/mL) were incubated with the H. androsaemum
ethanol:water extract at a concentration of 25 mg/mL for 4 h as de-
scribed for time kill curve procedure. After this time, the cells were
washed once with PBS and then stained with 1 μg PI/mL for 30 min.
The cells were rinsed again with PBS and ﬁnally resuspended in
200 μL for ﬂow cytometry analysis using EC800™ ﬂow cytometer ana-
lyzer (Sony Biotechnology). Scattergram analyses were performed to
evaluate morphological changes (size and complexity) and a total of
2000 events were accounted. The percentage of stained cells at FL3
(620 nm, red), representing cells with severe lesions of the membrane,
was quantiﬁed.2.6.3. Effect on Candida bioﬁlms
A) Bioﬁlm formation
In order to evaluate the effect of H. androsaemum ethanol:water ex-
tract on Candida species' bioﬁlm formation, the extract was added at the
beginning of their formation. For that, Candida cells were grown on SDA
for 24 h at 37 °C, then inoculated in SDB and incubated for 18 h at 37 °C
under agitation at 120 rpm. After incubation, cells were harvested by
centrifugation at 3000g for 10 min, at 4 °C, and washed twice with
15 mL of phosphate-buffered saline (PBS; pH 7; 0.1 M). Volumes of
100 μL of extract (2 × ﬁnal concentration) in RPMI 1640 medium
were added to each well of microtiter plates. Subsequently, 100 μL of
standardized yeast cell suspension (2 × 105 yeasts/mL) was added
and plates were incubated at 37 °C on a shaker at 120 rpm/min for
24 h to allow bioﬁlm formation. The extract concentrations used in
this study (12.5 mg/mL and 25 mg/mL) were based on our previous
ﬁndings of antimicrobial susceptibility. Negative controls (200 μL of
only RPMI 1640 medium) were also included.
Bioﬁlms were analyzed by CFUs determination. For that, after 24 h
the total medium was removed and the bioﬁlms washed once with
200 μL of PBS. Then, the bioﬁlms were scraped from the respective
wells and the suspensions vigorously vortexed for approximately
2min to disaggregate cells from thematrix (Alves et al., 2014). Serial di-
lutions were made in PBS, plated onto SDA and incubated for 24 h at
37 °C. The results were presented in terms of log CFUs.Table 1
In vitro antioxidant, cytotoxic and anti-inﬂammatory properties of the H. androsaemum
ethanol:water extract (mean ± SD).
H. androsaemum
Positive
controla
Antioxidant activity (EC50, μg/mL)
DPPH scavenging activity (RSA) 96 ± 3 41 ± 1
Reducing power (RP) 103 ± 1 41 ± 2
β-carotene bleaching inhibition (CBI) 155 ± 5 18 ± 1
TBARS inhibition (LPI) 36 ± 1 23 ± 1
Cytotoxic activity (GI50 values, μg/mL)
MCF-7 (breast carcinoma) 106 ± 11 0.91 ± 0.04
NCI-H460 (non-small cell lung cancer) 215 ± 13 1.0 ± 0.1
HeLa (cervical carcinoma) 205 ± 18 1.9 ± 0.1
HepG2 (hepatocellular carcinoma) 100 ± 7 1.1 ± 0.2
Hepatotoxicity (GI50 values, μg/mL)
PLP2 N400 3.2 ± 0.2
Anti-inﬂammatory activity (EC50 values, μg/mL)
NO production inhibition 179 ± 17 16 ± 1
a Positive controls, trolox, ellipticine and dexamethasone, were used for antioxidant,
cytotoxic and anti-inﬂammatory activity assays, respectively. EC50 values correspond to
the extract concentration achieving 50% of antioxidant/anti-inﬂammatory activity or 0.5
of absorbance in reducing power assay. GI50 values correspond to the extract concentra-
tion achieving 50% of growth inhibition in human tumor cell lines or in liver primary
culture PLP2.2.7. Analysis of phenolic compounds
HPLC (Hewlett–Packard 1100, Agilent Technologies, Santa Clara,
USA) was used to determine phenolic composition of the extract in
the conditions previously described (Barros et al., 2012). Double online
detectionwas carried out in a diode array detector (DAD) using 280 nm
and 370 nm as preferred wavelengths and in amass spectrometer (MS)
connected to the HPLC system via the DAD cell outlet. Phenolic com-
pounds were identiﬁed by comparing their retention time, UV–vis and
mass spectra with those obtained from standard compounds, when
available. Otherwise, peaks were tentatively identiﬁed comparing the
obtained information with available data reported in the literature. For
quantitative analysis, a calibration curve (1–100 μg/mL) for each avail-
able phenolic standard was constructed based on the UV signal:
chlorogenic acid (y = 304.25x−248.06; R2 = 0.999); protocatechuic
acid (y = 258.17x + 328.45; R2 = 0.998); p-coumaric acid (y =
706.09x + 1228.1; R2 = 0.999); epicatechin (y = 163.23x + 39.586;
R2 = 0.999); naringenin y = 539.98x + 161.46; R2 = 0.999); taxifolin
(y = 224,31x + 148,41; R2 = 0.999), and quercetin-3-O-glucoside
(y = 336.36x + 358.06; R2 = 0.998). For the identiﬁed phenolic com-
pounds forwhich no commercial standardwas available, the quantiﬁca-
tion was performed using the calibration curve of another similar
compound. Analyses were carried out in triplicate and the results
were expressed in mg per g of dried extract.2.8. Statistical analysis
All statistical tests were performed using IBM SPSS Statistics for
Windows, version 22.0. (IBM Corp., Armonk, NY, USA), and the means
were compared using Tukey's honestly signiﬁcant difference (HSD)
multiple comparisons test and further coupled to Welch to verify the
equality.
3. Results and discussion
3.1. Antioxidant activity
Free radicals, among them reactive oxygen species (ROS), play
an important role as triggers in a wide variety of diseases, such as
(neuro)degenerative and metabolic disorders, and even cancer
(Fernandez-Panchon, Villano, Troncoso, & Garcia-Parrilla, 2008; Li
et al., 2014). Numerous studies have been addressed to discover effec-
tive antioxidant compounds, their active concentrations and related
modes of action, being currently considered one of the highest hot
topics among the scientiﬁc community (Dato et al., 2013; Espín,
García-Conesa, & Tomás-Barberán, 2007). In fact, a relation between
premature aging, longevity impairment and oxidative stress status is
known to exist, although despite the intensive investigation a general
consensus was not established (Halliwell, 2012). On this ﬁeld, phenolic
compounds seem to be promissory antioxidant agents (Carocho &
Ferreira, 2013; Fernandez-Panchon et al., 2008). Thus, and aiming to
put forward alternative sources of phenolic compounds, the antioxidant
potential of the H. androsaemum ethanol:water extract was evaluated
using four different in vitro assays. The results are given in Table 1. The
most relevant effect was observed in the LPI assay, followed by RSA,
RP and CBI assays, whichmeans that compounds present in the studied
H. androsaemum extract act mainly as lipid peroxidation inhibitors.
Valentão et al. (2004) also concluded that the hepatoprotective effects
of H. androsaemum mainly derived from its strong ability to inhibit
lipid peroxidation, which was in part attributed to its phenolic compo-
sition. The authors achieved a concentration-dependent (16, 62 and
250 μg/mL) effective inhibition of lipid peroxidation, by measuring the
levels of MDA equivalents. However, at the highest concentration, the
obtained result was not so good as the positive control. Other authors
also reported radical scavenging effects when assessing the antioxidant
capacity of theH. androsaemum extract. Thus, Rainha et al. (2011)work-
ing with aqueous extracts from the aerial parts of different Hypericum
species, concluded that H. androsaemum not only exerted a strong free
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linoleic acid oxidation. In the same line, Valentão et al. (2002) evaluat-
ing the antioxidant potential of aqueous extracts prepared from
H. androsaemum leaves, described their action as strong scavengers of
reactive oxygen species, mainly superoxide radicals (IC50 =
2.9 μg/mL). Similar radical scavenging effects of H. androsaemum aque-
ous extracts were also described by Hernandez et al. (2010) and
Ramos et al. (2013); these latter also reported a signiﬁcant ability to re-
pair DNA damages. By comparing these results with those previously
cited, it is clearly evident that the geographic origin of plant species
and solvent extraction, amongmanyother factors, exert a direct and de-
terminant effect on its chemical composition, and consequently biolog-
ical potential. Interestingly, all the previous cited authors correlated
the observed biological effects with the chemical composition of
H. androsaemum extract, namely with its abundance in phenolic com-
pounds. Chlorogenic acids have been mentioned as the most abundant
phenolic acids present in this extract (nearly 60%) (Hernandez et al.,
2010; Rainha et al., 2011; Ramos et al., 2013; Valentão et al., 2002;
Valentão et al., 2004), and therefore responsible for the observed
antioxidant potential. Additionally, and not least important to
emphasize, is that quercetin derivatives, although present in small ex-
tent, may also contribute for the ﬁnal biological potential. Hence,
H. androsaemummay be considered a source of bioactive molecules, es-
pecially phenolic compounds, with antioxidant potential and could act
as reducing agents, hydrogen donators, singlet oxygen quenchers,
peroxynitrites, superoxide, hydroxyl and peroxyl radical's scavengers.
3.2. Cytotoxic activity in tumor and non-tumor cells
No toxicity was observed for non-tumor porcine liver cells (PLP2) at
concentrations up to 400 μg/mL of the studied H. androsaemum extract,
in contrast with the high hepatotoxicity registered for the positive con-
trol ellipticine (Table 1). However, the extract was able to inhibit differ-
ent human tumor cell lines: breast (MCF-7), non-small cell lung (NCI-
H460), cervical (HeLa) and hepatocellular (HepG2) carcinoma, al-
though relatively high concentrations were required (Table 1). Hepato-
cellular carcinoma cells (GI50 = 100 ± 7 μg/mL) were the most
susceptible to the H. androsaemum extract, followed by breast
(GI50 = 106 ± 11 μg/mL), cervical (GI50 = 205 ± 13 μg/mL) and non-
small cell lung (GI50 = 215 ± 13 μg/mL) carcinoma cell lines. The
obtained results could be due to the diversity and the occurrence of syn-
ergistic reactions between the different bioactive compounds present in
the extract. In addition, it is also important to note that despite the
obtained results were not highly promising when compared with the
positive control ellipticine, this compound was also highly toxic for
non-tumor cells at very low concentrations. As previously mentioned,
the origin of the extract as well as the type of the extraction solvent
may interfere with the ﬁnal observed effects. For example, Xavier et al.
(2012) reported the in vitro anti-proliferative and pro-apoptotic effects
ofH. androsaemum aqueous extracts in human colon carcinoma-derived
cell lines, and described an IC50 concentration of 65 μg/mL. Chlorogenic
acid was the most abundant phenolic compound in the extract studied
by these authors, 54 μg/mg (Xavier et al., 2012), which is in agreement
with the herein tested ethanol: water extract, where two chlorogenic
acids, 5-O-caffeoylquinic acid and 3-O-caffeoylquinic acid were thema-
jority compounds. Thus, it seems that chlorogenic acids could be the
main responsible bioactive compounds for the observed cytotoxic po-
tential. Notwithstanding, the authors clearly emphasized that the ob-
served effect was not due to the presence of chlorogenic acid alone,
once using a concentration 20 times higher than the one present in
the extract, no positive effects were observed.
3.3. Anti-inﬂammatory activity
Inﬂammation is in the origin of numerous degenerative and meta-
bolic disorders, among which the most tremendous is cancer.Notwithstanding, the inﬂammatory process is a very complex process,
and in most of the cases the triggering factor cannot be identiﬁed, al-
though free radicals overproduction might be one of the reasons
(Aruoma, 2003; Soobrattee, Neergheen, Luximon-Ramma, Aruoma, &
Bahorun, 2005). Thus, and considering the observed antioxidant poten-
tial of the H. androsaemum ethanol: water extract, their anti-
inﬂammatory activity was also evaluated. A 50% inhibition of nitric
oxide (NO) production was observed at 178.78 ± 16.60 μg/mL
(Table 1). As far as we know, this would be the ﬁrst report on the
anti-inﬂammatory potential of H. androsaemum extracts. Considering
the obtained results, and the fact that the phenolic composition may
largely determine the observed effects, it is possible to infer that
chlorogenic acids apart from displaying a signiﬁcant antioxidant effect
also contributes to ameliorate the inﬂammatory processes. In fact, it
has been reported that substances with signiﬁcant antioxidant proper-
ties, also exert anti-inﬂammatory effects. For example, Chen & Kang
(2013) assessing the in vitro anti-inﬂammatory and antioxidant effects
of Capsicum annuum L. (red pepper) observed a direct correlation be-
tween antioxidant and anti-inﬂammatory effects, and that these effects
are directly dependent on its phenolic composition, namely in
chlorogenic and p-coumaric acids, which were respectively, the most
abundant phenolic compounds present. In addition, the authors also ob-
served considerable differences between the extracts obtained from the
pericarp, placenta and stalks, providing the last one the highest poten-
tial (Chen&Kang, 2013). On the other hand, Correia et al. (2005) aiming
to evaluate the antioxidant potential of Equisetum telmateia Ehrh. and to
determine its phenolic composition, observed that the content in
proanthocyanidins was high, being then isolated for further evaluation.
Moreover, and not least important to highlight was that
proanthocyanidins were identiﬁed in this matrix for the ﬁrst time by
these authors, in particular propelargonidins, which probably explains
the pronounced anti-inﬂammatory and antimicrobial effects of this
plant, apart from its signiﬁcant antioxidant potential (Correia,
González-Paramás, Amaral, Santos-Buelga, & Batista, 2005). In our
study, the contents of procyanidins were lower than those observed
by Correia et al. (2005) in ethyl acetate fractions; but ethanol: water ex-
tracts are considered safer and “greener” options.
3.4. Anti-Candida activity
3.4.1. Effect on Candida planktonic cells
A) Minimal inhibitory concentrations
As it can be observed in Fig. 1 (I), the extract was active against all
the tested strains, with MIC values ranging from 1.56 to 12.5 mg/mL.
Fig. 1 (II) shows the number of counts (log CFU/mL) for the susceptible
Candida strains treated with the extract. The most pronounced
fungistatic effect was observed against C. glabrata (Fig. 1(II) D) and
C. parapsilosis (Fig. 1(II) C), for which the two assayed strains were sen-
sitivewith an observed effect thatwas directly related to the concentra-
tion tested. Variable effects were observed between each of the two
strains in the other two Candida species considered. There are no doubts
that both morphological and structural factors speciﬁc of each of the
tested Candida species may explain the observed results, but it is also
important to emphasize the different susceptibilities of Candida species,
i.E. candida species with high evidences of drug-resistance (such as Can-
dida tropicalis strains) should normally display a low sensibility to the
tested plant extract. In fact, this effect was observed, but themagnitude
of growth inhibition was dependent to the concentration used. By com-
paring the obtained results with the positive control, ﬂuconazole, they
were not really promissory, being the MIC values to C. albicans ATCC
90028, C. glabrata ATCC 2001, C. parapsilosis ATCC 22019 and
C. tropicalis ATCC 750, respectively, 0.125, 8, 0.5 and 0.5 μg/mL. Howev-
er, it is important to point out that in this case a pure compound was
used, while in the natural extract are present a rich pool of
Fig. 1. In vitro effects of theH. androsaemum ethanol:water extract on Candida strains planktonic cells. I)Minimal inhibitory concentrations (MICs values). II) Logarithmof number Candida
species cells grown in the presence of increased concentrations of H. androsaemum during 24 h. (A) Candida albicans; (B) Candida tropicalis; (C) Candida parapsilosis; and (D) Candida
glabrata. Error bars represent standard deviation. Statistical p value (represented by * or **) indicates concentrations that are signiﬁcantly different from control. *p b 0.05; **p b 0.01.
427I. Jabeur et al. / Food Research International 89 (2016) 422–431phytochemicals with different potentialities, being therefore of the ut-
most importance to access its effect both individually and mixtures of
several of those compounds, as well as its synergic potential with the
conventional drugs. Furthermore, it is also crucial to note that the chem-
ical composition of the teste plant extract largely determines its biolog-
ical potential; thus, and considering that 5-O-caffeoylquinic acid
followed by 3-O-caffeoylquinic acid were the most abundant phenolic
compounds present in the H. androsaemum ethanol:water extract, the
observed anti-Candida effect may be directly related by its abundance
at the concentrations tested.
B) Time-kill curve determination
The killing activity of the H. androsaemum ethanol:water extract,
plotted from log CFU/mL versus time (24 h), is represented in Fig. 2.
Analysis of the time-kill curves showed an inhibitory effect against
three of the tested species, C. tropicalis, C. parapsilosis and C. glabrata.
At a concentration of 25 mg/mL of extract, a substantial time-
dependent reduction in the number of cultivable cells was observed
compared with the control group. The more pronounced effect was ob-
served in C. glabrata, with a decrease≥99% of the cells (2.2 logs) at 24 h,
comparatively to control group. For the C. tropicalis and C. parapsilosis
strains the reduction was about 90% (1.5 log) up to 12 h with a promi-
nent re-growth after that time. However, no effects were observed on
the pattern growth of C. albicans. The highest MIC value for the extract
was also obtained in this species compared with C. tropicalis,
C. parapsilosis and C. glabrata.
C) Cell membrane disruption
Flow cytometry analyses were used to investigate the effect of the
H. androsaemum ethanol:water extract on the membrane integrity of
fungal cells. PI is a nucleic acid-binding ﬂuorescent probe commonly
employed to evaluate the effect of drugs on cell membranes. Cells
with severe membrane lesions leading to inherent loss of viability will
internalize PI, resulting in an increase in red ﬂuorescence (Pina-Vaz
et al., 2001). The PI penetration in yeast cells treated with the extract
is summarized in Fig. 3. After incubation periods of 4 h with 25 mg/mL
of the extract, Candida cells were affected in a different manner.Interestingly, the extract was able to disintegrate cell membranes of
C. glabrata and C. tropicalismore than to the other species, whereas no
signiﬁcant differences between C. albicans, C. parapsilosis and control
were observed (Fig. 3). The obtained results are in accordance with
the observations made both on the Candida cells growth inhibition
(Fig. 1) and time-kill curve assays (Fig. 2). These data indicate that
C. tropicalis and C. glabrata cells are more sensitive to the treatment
with H. androsaemum evidencing high membrane permeability when
compared to untreated cells. In addition, the involved mechanisms of
the antimicrobial potential conferred by the main phenolic compounds
present in H. androsaemum remain poorly characterized.
3.4.2. Effect on Candida bioﬁlms
Bioﬁlms are structured communities that can cause serious medical
problems, such as indwelling device-related infections. Recent data
show that over 65% of all hospital infections derived from bioﬁlms
(Azevedo et al., 2014). Bioﬁlm-associated Candida cells are resistant to
a wide spectrum of available antifungal drugs (Ramage, Mowat, Jones,
Williams, & Lopez-Ribot, 2009). This scenario has exacerbated by the in-
creasing demand for safer and more effective antifungal therapies, and
the search for new and better agents that target fundamental biological
processes and/or pathogenic determinants (Khan, Ahmad, Cameotra, &
Botha, 2014).
As presented in Fig. 4, Candida strains bioﬁlm formation was attenu-
ated in the presence of the H. androsaemum extract in the cases of
C. tropicalis and C. glabrata, for which a reduction N90% of the cultivable
cellswas observed on the bioﬁlms treatedwith the extract at concentra-
tions of 12.5 and 25 mg/mL. Candida glabrata strains presented the
highest bioﬁlm reduction (~2.4 to 4.1 log units) (Fig. 4D), followed by
C. tropicaliswith a reduction around ~1 to 3 log units (Fig. 4B) compared
with the control group. No signiﬁcant differences were observed for
C. albicans and C. parapsilosis bioﬁlms in relation to the untreated
bioﬁlms (Fig. 4A and C). The results obtained for C. glabrata and
C. tropicalis seem to be promising, once speciesNCAC exhibitmore resis-
tance to conventional antifungals. Moreover, C. glabrata are intrinsically
resistant to ﬂuconazole and other azoles, the most commonly used
drugs to treat Candida infections.
Despite the weaker results in comparison with the positive controls
used, the obtained data may also open new perspectives to discover
more effective and safer antifungal drugs, considering that themajority
Fig. 2. Killing kinetics of the H. androsaemum ethanol:water extract against Candida species. A: Candida albicans ATCC 90028; B: Candida tropicalis ATCC 750; C: Candida parapsilosis ATCC
22019; D: Candida glabrata ATCC 2001. Standardized yeast cells suspensions were exposed to 25mg/mL of H. androsaemum extracts. At determined time intervals, samples were serially
diluted and plated for colony counts. Each data point represents mean result ± standard deviation (error bars) from three experiments. Statistical p value (represented by *) indicates
concentrations that are signiﬁcantly different from control. *p b 0.05.
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example, Pendota, Aderogba, Ndhlala, & Staden (2013) evaluated the
antifungal potential of Buddleja salviifolia (L.) Lam. leaf extracts and its
isolated compounds, and observed thatMIC values obtained for hexane,Co
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Fig. 3. Effect of the H. androsaemum ethanol:water extract on the Candida species
membrane. The percentage of PI-stained cells was analyzed by ﬂow cytometry with and
without exposure to H. androsaemum extracts for a period of 4 h. Statistical p value
(represented by **) indicates concentrations that are signiﬁcantly different from control.
*p b 0.01.dichloromethane, ethyl acetate and butanol extracts, as also for individ-
ual compounds were higher than those obtained for the positive con-
trol. However, the obtained MIC values for the individual compounds
were lower than those for the whole extracts (Pendota et al., 2013). It
means that a wide variety of metabolic and biochemical reactions may
occurs between the different phytochemicals present in natural matri-
ces, some of them improving the ﬁnal biological effect while other
ones exert an antagonistic effect.
3.5. Phenolic compounds
The chromatographic proﬁle of the H. androsaemum ethanol:water
extract recorded at 280 nm is shown in Fig. 5, and peak characteristics,
tentative identities and phenolic compounds quantiﬁcation are present-
ed in Table 2. Compounds 2 (protocatechuic acid), 4 (5-O-caffeoylquinic
acid), 6 (epicatechin), 11 (taxifolin), 12 (quercetin-3-O-glucuronide)
and 13 (quercetin-3-O-glucoside)were positively identiﬁed by compar-
ison with authentic standards, as also by their MS fragmentation pat-
tern, retention time and UV–vis characteristics. 5-O-Caffeoylquinic
acid and quercetin derivatives have been reported in methanol extracts
from the aerial parts (Rainha et al., 2011) and leaves (Porzel et al., 2014;
Valentão et al., 2003) of H. androsaemum, and in aqueous extracts from
the leaves (Valentão et al., 2002; Valentão et al., 2004).
Compound 1 ([M-H]− at m/z 353) was identiﬁed as 3-O-
caffeoylquinic acid based on its fragmentation pattern, yielding a base
peak at m/z 191 (deprotonated quinic acid) and an ion at m/z 179
[caffeic acid-H]− with an intensity of 47% of the base peak, as reported
by Clifford, Johnston, Knight and Kuhnert (2005, 2003), and Clifford,
Johnston, Knight, and Kuhnert (2003). Similarly, compound 3 ([M-H]−
at m/z 337) was tentatively identiﬁed according to its MS2 fragmenta-
tion as 3-O-p-coumaroylquinic acid (Clifford et al., 2003; Clifford et al.,
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Fig. 4. Effect of theH. androsaemum ethanol:water extract on Candida strains bioﬁlm. Logarithm of number of colony form units (CFUs) of different Candida albicans (A), Candida tropicalis
(B), Candida parapsilois (C) and Candida glabrata (D) bioﬁlm strains, treatedwith different concentrations of theH. androsaemum extracts.Candida cellswere allowed to forming bioﬁlm for
24 h with extract at 37 °C. Controls: bioﬁlm grown in RPMImedium in the absence of extract. Error bars represented in graphics indicate the standard deviation; ** correspond to p b 0.01.
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(Valentão et al., 2002; Valentão et al., 2004) and methanolic (Porzel
et al., 2014; Valentão et al., 2003) extracts from leaves and in aerial
parts (Rainha et al., 2011) of H. androsaemum.
Compounds 5, 7, 8 and 10 showed UV spectra with λmax 280 nm,
characteristic of proanthocyanidins. Peaks 5 and 10 presented
pseudomolecular ions corresponding to (epi)catechin dimers ([M-H]−
at m/z 577) and compounds 7 ([M-H]− at m/z 865) and 8 ([M-H]− at
m/z 1153) to a trimer and a tetramer, respectively. The positive identiﬁ-
cation in the extract of epicatechin as the only ﬂavan-3-ol monomer
would suggest an epicatechin-based identity for those peaks. Thus, the
compounds might correspond to the B-linked epicatechin series, i.e.,
procyanidin dimer B2 (epicatechin-4,8-epicatechin, peak 5), trimer C1Time (min)0 10 20
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Fig. 5. Phenolic compounds proﬁle of theH. androsaemum ethanol:water extract recorded
at 280 nm.(epicatechin-4,8-epicatechin-4,8-epicatechin, peak 7) and the (4,8)-
linked epicatechin tetramer (peak 8), whereas the late elution of peak
10 suggests a (4,6) linkage (i.e., epicatechin-4,6-epicatechin; dimer
B5). These identities would also be coherent with their expected rela-
tive order of elution (Santos-Buelga, García-Viguera, & Tomás-
Barberán, 2003). This identiﬁcation differs from the one recently report-
ed by Ramalhete et al. (2016), who indicated the presence of (+)-cate-
chin and related proanthocyanidins inmethanol extracts obtained from
the aerial parts of this plant.
Compounds 14 ([M-H]− at m/z 463) and 15 ([M-H]− at m/z 433)
presented UV spectra (λmax 354–356 nm) and the production of a
unique fragment ion atm/z 301 ([quercetin-H]−), which allowed their
identiﬁcation as quercetin-O-hexoside and quercetin-O-pentoside, re-
spectively. Finally, compound 9 ([M-H]− at m/z 449) was tentatively
identiﬁed as eriodictyol-O-hexoside, based on its UV spectrum and the
product ion observed atm/z 287. No further conclusion about the nature
and position of the substituting sugar of these compounds can bemade
from the obtained LC-DAD-MS data. Similar quercetin glycosides have
been indicated in aqueous (Valentão et al., 2002; Valentão et al., 2004)
and methanol (Porzel et al., 2014; Rainha et al., 2011; Valentão et al.,
2003) preparations of the plant, whereas, to the author's best knowl-
edge, the presence of eriodictyol-O-hexoside has not been previously
reported.
Overall, 5-O-caffeoylquinic acid followed by 3-O-caffeoylquinic acid
were the majority phenolic compounds present in the H. androsaemum
ethanol:water extract, and they should account for the observed antiox-
idant, cytotoxic, anti-inﬂammatory and anti-Candida activities.
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